Crescent Capital BDC Inc
NASDAQ:CCAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
CN |
Crescent Capital BDC Inc
Non-Reccuring Items
Crescent Capital BDC Inc
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Crescent Capital BDC Inc
NASDAQ:CCAP
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ameriprise Financial Inc
NYSE:AMP
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
KKR & Co Inc
NYSE:KKR
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
BlackRock Inc
NYSE:BLK
|
Non-Reccuring Items
-$246m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
-12%
|
|
|
Bank of New York Mellon Corp
NYSE:BK
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Blackstone Inc
NYSE:BX
|
Non-Reccuring Items
$6.6m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-22%
|
|
Crescent Capital BDC Inc
Glance View
Crescent Capital BDC Inc. is a an externally managed, closed-end, non-diversified management investment company. The company is headquartered in Los Angeles, California and currently employs 200 full-time employees. The company went IPO on 2020-02-03. The Company’s primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. The firm will seek to achieve its investment objectives by investing primarily in secured debt and unsecured debt, as well as related equity securities of private United States middle-market companies. The firm may purchase interests in loans or make debt investments, either directly from its target companies as primary market or private credit investments, or primary or secondary market bank loan or high yield transactions in over-the-counter market. The firm in-addition is also focused to invest in private credit transactions, and in certain circumstances it will also invest in syndicated loans and bonds. The firm is managed by Crescent Cap Advisors, LLC.
